Which vaccines should be avoided in patients receiving chemotherapy?
In a comparison of vaccinated vs unvaccinated young adults, oral HPV infection prevalence was found to be substantially lower in persons 18 to 33 years who received at least 1 vaccine-dose during the study years.
Axalimogene filolisbac, an intravenous vaccine currently in clinical trials, could prevent often-fatal cervical cancer relapse.
Seasonal influenza vaccination was associated with increased rates of immunologic toxicity in patients with lung cancer receiving PD-1/PD-L1 immunotherapy blockade.
ASCO offers global recommendations for HPV vaccination tailored to structural resource levels of regions.
Self-persuasion is more effective than external persuasion for motivating low-income parents to vaccinate their children against HPV.
The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.
A comparison of administering the influenza vaccine concurrently with chemotherapy with that of administration within the cytopenic period during 3-week chemotherapy cycles determined which schedule was the optimal timing for vaccination administration in this group.
A recent study examined the current economic burden attributable to vaccine-preventable diseases among U.S. adults.
Although HPV vaccination is expected to decrease the cancer burden from HPV across all racial and ethnic groups, some disparities are expected to persist and widen if their causes are not addressed, including lack of access to screening, timely diagnoses, and treatment.
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
Teen girls living in high-poverty and in majority Hispanic communities had the highest rates of having received at least 1 dose of the HPV vaccine compared with those in low-poverty communities and in communities of other racial or ethnic compositions.
Many pediatricians and primary care physicians reported communicating about HPV vaccination with parents in ways that likely discourage them from having their children vaccinated.
Physicians failing to recommend it or adequately explain its benefits to parents could be a factor.
A sizable minority of doctors does not strongly endorse HPV vaccination nor deliver timely recommendations.
Immunization protects against sexually transmitted disease and certain cancers, health experts say, but only two U.S. states mandate vaccination.
Reports on outbreaks of measles, pertussis in past year may have shifted opinions on vaccination.
Researchers note that CDC recommends vaccination at age 11 or 12, but only half of girls receiving the vaccination get it at the proper age.
An experimental breast cancer vaccine boosts immune response and appears to slow spread in those with advanced disease.
Vaccine is effective even among older adults who subsequently undergo chemotherapy.
The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a recent study.
The HPV vaccine protects against cancers of the cervix, throat, rectum, and penis, but too few are receiving it.
Combination vaccine significantly improves overall survival in pancreatic cancer, compared with single-component vaccine.
This fact sheet examines the role of vaccines for the prevention and treatment of cancer, including current areas of research.
Patients with recurrent GBM treated with an experimental vaccine made from the patient's own resected tumor tissue showed an improved survival compared with historical patients who received the standard of care alone, according to an analysis of a phase 2 trial of this vaccine.
Vaccination with GM2/KLH-QS-21 does not benefit patients with stage II melanoma, according to a recently published study.
Vaccines and monoclonal antibodies are promising new treatments for patients with follicular lymphoma.
A new vaccine, derived from the patient's tumor cells, is designed to jumpstart the patient's immune system to attack and kill cancer cells.
A newly reported clinical trial used a vaccine that stimulated dendritic cells to treat newly diagnosed advanced melanoma.
HPV vaccination is widely offered but underused; many doctors continue to offer annual Pap smears.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|